Boulder Peptide Symposium, September, 2016

CDG Therapeutics was invited to present at the Boulder Peptide Symposium (http://boulderpeptide.org), Boulder, Colorado.

Title: p28, a Non-toxic, Orphan/Rare Pediatric Disease Designated, Cell Penetrating Peptide for the Treatment of Pediatric Brain Tumors